Interdisciplinary Group Care for the Treatment of Endometriosis-associated Pain
Launched by WASHINGTON UNIVERSITY SCHOOL OF MEDICINE · Aug 8, 2024
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new program called Peer Empowered Endometriosis Pain Support (PEEPS) to see if it helps reduce chronic pelvic pain in women with endometriosis. The program lasts for 8 weeks and involves group sessions where participants learn about managing their pain and share experiences with peers. Researchers want to find out if PEEPS is more effective at helping with pain and improving quality of life compared to just providing education about endometriosis.
To be eligible for this trial, you need to be a woman aged 18 to 48 who has been diagnosed with endometriosis and has had chronic pelvic pain for at least six months. You should be able to attend at least six out of eight weekly sessions on the Washington University campus and be comfortable reading and speaking English. If you decide to participate, you'll fill out surveys about your quality of life before and after the program, and you may also take part in discussions about your experience. This trial is currently recruiting participants, so it’s a great opportunity for those seeking support and management strategies for endometriosis-related pain.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Age 18-48 years
- • Operative confirmation of endometriosis
- • Chronic pelvic pain (pain perceived to originate from the pelvis, not exclusively during menses, lasting ≥6 months)
- • No plan to have surgery before or during the PEEPS cohort
- • Able to attend at least six of the eight 2-hour weekly sessions on the Washington University campus
- • Comfort reading and speaking English as groups and materials are in English
- Exclusion Criteria:
- • Currently pregnant
- • Severe physical impairment (limiting yoga participation)
- • History of hip or spine surgery given increased risk of harm and need for extensive activity modification
- • Current or history of psychiatric disorder with psychosis in order to minimize risk of adverse mental health effects to participants
- • Opioid use ≥ 5 days in the past 3 months, other than for the 6-week post-operative period
- • History of surgical removal of bilateral ovaries
About Washington University School Of Medicine
Washington University School of Medicine is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research, education, and patient care. With a strong emphasis on translating scientific discoveries into practical applications, the institution conducts a diverse array of clinical trials aimed at improving treatment outcomes and enhancing the understanding of various medical conditions. Its collaborative environment fosters partnerships between researchers, clinicians, and community stakeholders, ensuring that the trials not only contribute to scientific knowledge but also address the pressing health needs of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saint Louis, Missouri, United States
Patients applied
Trial Officials
Whitney Ross, MD
Principal Investigator
Washington University School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported